the precise solution by sfm
Freeze-drying has proven to be effective for preservation in the manufacture of sensitive biopharmaceutical products. The requirements of this complex process are high. Lyophilized active ingredients have several advantages. What are they, and what factors need to be considered during reconstitution?
Freeze-drying (lyophilization) has been an important step in the manufacture and development of pharmaceutical drugs since the beginning of the 21st century.1 As a basic principle, water is withdrawn from the solution of the active ingredient. Lyophilization affects the product quality in many ways: chemical and physical degradation reactions are slowed down or even completely stopped in the freeze-dried state. This results in improved long-term stability. Freeze drying has become the most common formulation of biopharmaceutical medications in recent years.1
Lyophilization is a complex process, and the relevant processes must be optimized for the respective medication. Several stages are involved:2
Cold: The aqueous solution of the active ingredient freezes in the vial. This step is a prerequisite for low-temperature drying.
Vacuum: In a vacuum, the frozen solvent vaporizes without passing through a liquid phase (sublimation).
Heat: Raising the temperature accelerates sublimation.
Condensation: The vaporized solvent condenses on the walls of the vacuum chamber and is removed. This completes the separation process.3
The result is a virtually anhydrous, freeze-dried cake of the medication.1
Freeze-drying is worthwhile because lyophilized active ingredients have several useful advantages:
The chemical and biochemical properties of the active ingredient remain unchanged due to the gentle freeze-drying process.
The freeze-dried medication cake remains sterile and stable in the vial for a long time while in storage.
Transport and storage are simplified by the small footprint.
A decisive advantage of lyophilized substances can be seen in the reconstitution of the active ingredient. This is because the porous structure of lyophilized active ingredients ensures that they dissolve quickly in an aqueous solution. However, there are high demands on the transfer system.
Reliable and gentle reconstitution is important in order to protect the high-quality medication that has passed through the complex lyophilization process. Incorrect reconstitution can lead to a loss of quality or even render the solution of active ingredient useless. In addition to the safety issues for the patient, this can also have negative economic effects. The nextaro® premium transfer system from sfm medical devices GmbH reconstitutes the lyophilizate gently and completely due to its special geometry. In addition, nextaro® can be adapted to the individual characteristics of the components to optimize the reconstitution process. The result is a high-quality solution containing the active ingredient that is ready for injection.
1. Nireesha GR, Divya L, Sowmya C et al. Lyophilization/Freeze Drying - An Review. International Journal of Novel Trends in Pharmaceutical Sciences 2013; 3: 87-98. https://www.scienztech.org/index.php/ijntps/article/view/96
2. Kawasaki H, Shimanouchi T, Kimura Y. Recent Development of Optimization of Lyophilization Process. Journal of Chemistry 2019; 2019: 9502856. https://doi.org/10.1155/2019/9502856
3. Kuu WY, Hardwick LM, Akers MJ. Correlation of laboratory and production freeze drying cycles. Int J Pharm 2005; 302: 56-67. https://www.ncbi.nlm.nih.gov/pubmed/16099610
In recent years, sustainability has become increasingly important in the medical industry. In particular, companies are increasingly focusing on the development and manufacture of sustainable medical products.
The current Covid-19 pandemic poses great challenges for the world. The situation should be controllable with global vaccination programs, but it will require an enormous logistic effort in terms of transport, storage and administration of the vaccines. How can freeze-dried vaccines simplify these processes?
Freeze-drying (lyophilization) is one of the most important pharmaceutical processes. It ensures the shelf life and storability of sensitive drugs. In which areas are freeze-dried active ingredients preferred and which medication groups are suitable for this process?
Top off your high quality application set with the device it deserves.
Please do not hesitate to contact us.
nextaro® is manufactured and distributed by:
sfm medical devices GmbH, Brückenstraße 5, 63607 Wächtersbach (Germany)
